Technology + System Integration
Publication date: 20 March, 2025
Publication date: 20 March, 2025
The integration of licensed, newly developed technologies into automated environments used by established laboratory equipment suppliers and drug screening service providers is driving progress in drug screening and the growth of the lab automation sector: while start-ups and academic collaborators generate heart organoids from pluripotent stem cells, for example, organoid-based drug screening is only made possible by AIcontrolled systems for fully automated organoid culture. But this is just one example of technology and data integration. In collaboration with the Society for Laboratory Automation & Screening (SLAS), the special ‘Technology and Process Integration’ offers the opportunity to present your innovations, joint product developments and services in an exciting editorial environment, just in time for SLAS Europe 2025 (20-22 May, Hamburg).
Drug developers, CROs, bioprocess developers, analytical experts, formulation and drug delivery specialists, providers of research equipment, AI and ML companies, as well as lab automation experts will have the opportunity to present their latest developments, products, services, and equipment in this special. EuropEan BiotEchnology goes out to decision makers throughout the entire European Life Sciences sector. Take advantage of the journal’s highly relevant readership and grab this opportunity to target your audience!
Process and technology integration/services: Automated culture of adherently growing or cryopreserved cells, assay-based testing of novel modalities such as condensates, RNA drugs, conjugates, engineered cell and antibody therapies and iterative AI-guided optimisation, automated manufacturing, AI-guided process development, analytical testing, formulation and optimisation, quality assurance, delivery strategies, equipment etc.
Editorial Deadline 07-03-2025
Editorial Contact:
Booking Deadline 07-03-2025
Marketing Contact:
Publication Date 20-03-2025
Marketing Contact: Thomas Gabrielczyk Oliver Schnell Andreas Macht
Tel.: +49-30-264921-50
Fax: +49-30-264921-11
t.gabrielczyk@biocom.de
Tel.: +49-30-264921-45
Fax: +49-30-264921-11
o.schnell@biocom.de
Tel.: +49-30-264921-54
Fax: +49-30-264921-11
a.macht@biocom.de
European Biotechnology Network
Europe: european-biotechnology.net
Austria: lifescienceaustria.at
United States: slas.org
Europe: medicinesforeurope.com
Germany: gasb.de
Italy: assobiotec.federchimica.it
Spain: asebio.com
Switzerland: swissbiotech.org
Ireland: ibec.ie/ibia
Portugal: www.p-bio.org
Young European Biotech Network
Europe: yebn.eu
Austria: biotechaustria.org
Denmark: danskbiotek.dk The Netherlands: hollandbio.nl
UK: biopartner.co.uk
France: france-biotech.org
Sweden: swedenbio.com
Norway: bioteknologiradet.no
Hungary: hungarianbiotech.org
Europe: cebr.net
Finland: suomenbioteollisuus.fi Belgium: bio.be
EuropE an BiotEchnology covers the biotechnology sector of the current 27 EU member states, Norway, Switzerland, and UK. If you would like to subscribe, please refer to european-biotechnology.com